COMPASS Pathways Archives

Psychedelics News

COMPASS Pathways

Breaking News

19 Feb 2026

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

By Madison Roberts

Breaking News

16 Aug 2023

COMPASS Pathways Announces Capital Raise of Up to $285 Million

COMPASS Pathways has announced a capital raise of up to $285 million, the largest cash injection the industry has seen in quite some time....

By Microdose NewsDesk

Industry

25 Jul 2023

Positive Results Published for Compass Pathways’ COMP360 For Anorexia

A study using Compass Pathways’ COMP360 psilocybin compound for anorexia was published in Nature Medicine....

By Jason Najum

Breaking News, Science

17 Jul 2023

Positive Data From COMPASS Pathways’ Phase 2 Trial Combining Psilocybin & SSRIs

Results of COMPASS Pathways’ study suggests that SSRIs do not interfere with the potential therapeutic effect of COMP360...

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Finance

6 Jun 2023

Compass Pathways’ Stock Soars as COMP360 Receives Patent Victory

Compass Pathways’ COMP360 has just received additional support for its IP strategy, with the US Patent and Trademark Office upholding patent protections on the compound....

By Microdose NewsDesk

Industry

1 Jun 2023

Compass Pathways’ COMP360 Produces 50% Long-Term Depression Remission in Cancer Patients

Late last week we received news that Compass Pathways' psilocybin compound COMP360 produced extremely positive results in alleviating depression results in cancer patients....

By Jason Najum

Finance

12 May 2023

COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights

COMPASS Pathways reported its financial results for the first quarter 2023 and gave an update on recent progress across its business....

By Microdose NewsDesk

Finance

8 May 2023

Which Psychedelic Medicine Companies Have the Best Financials?

As I have written many times before, the success or failure of a psychedelic medicine company depends heavily on its financial position....

By James Hallifax

Industry

2 May 2023

American Medical Association to Issue First Code for Psychedelic Therapies to COMPASS and MAPS

COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, and MAPS Public Benefit Corporation (MAPS PBC), a...

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result